Filing Details

Accession Number:
0001127602-23-030485
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-27 16:11:38
Reporting Period:
2023-12-27
Accepted Time:
2023-12-27 16:11:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061983 Cytokinetics Inc CYTK Pharmaceutical Preparations (2834) 943291317
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235945 Wendall Wierenga 350 Oyster Point Blvd
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-27 5,000 $4.44 23,653 No 4 M Direct
Common Stock Disposition 2023-12-27 5,000 $73.60 18,653 No 4 S Direct
Common Stock Acquisiton 2023-12-27 5,000 $4.44 23,653 No 4 M Direct
Common Stock Disposition 2023-12-27 5,000 $73.60 18,653 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2023-12-27 5,000 $0.00 5,000 $4.44
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2023-12-27 5,000 $0.00 5,000 $4.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2014-06-21 2024-05-21 No 4 M Direct
0 2014-06-21 2024-05-21 No 4 M Direct
Footnotes
  1. Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023.
  2. This option shall vest and become exercisable as to 10,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2015.